CVR: 37256641
DKK -14,505
Gross profit
Net result: DKK -21,600
No owners listed
CVR · view ownership and management
Director role ended: Jette Bjerrum
CVR · 24/06/2019
View the full event history
GlioPharma ApS was a Danish company of the type Anpartsselskab based in Kolding, founded in 2015 and dissolved in 2019. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. In 2018, the company reported a gross profit of DKK -14,505 and a net result of DKK -21,600. Equity in the 2018 report amounted to DKK 32,817.
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringNo. GlioPharma ApS is registered in the Danish CVR register with the status Dissolved and ceased on 24 June 2019.
GlioPharma ApS was founded on 25 November 2015.
GlioPharma ApS was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721900).
In 2018, GlioPharma ApS reported a gross profit of DKK -14,505.
GlioPharma ApS was located at c/o Beierholm, Birkemose Allé 27 1., 6000 Kolding.
The CVR number of GlioPharma ApS is 37256641.
As of June 24, 2019, Jette Bjerrum has stepped down as adm. dir. of GlioPharma ApS.
GlioPharma ApS was dissolved on June 24, 2019.
GlioPharma ApS has published its annual report for 2018. Gross profit came to DKK -14,505, and the net result was DKK -21,600.
As of September 19, 2018, John Bo Jacobsen has stepped down as chairman of GlioPharma ApS.
GlioPharma ApS has published its interim report for the period November 25, 2015 – April 30, 2017.
As of November 25, 2015, Jette Bjerrum is registered as adm. dir. of GlioPharma ApS.
As of November 25, 2015, John Bo Jacobsen is registered as chairman of GlioPharma ApS.
GlioPharma ApS was founded on November 25, 2015.
